{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:33:38Z","timestamp":1772253218185,"version":"3.50.1"},"reference-count":75,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i1.349","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T01:06:16Z","timestamp":1451523976000},"page":"349","source":"Crossref","is-referenced-by-count":16,"title":["Combination antiretroviral studies for patients with primary biliary cirrhosis"],"prefix":"10.3748","volume":"22","author":[{"given":"Ellina","family":"Lytvyak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wasilenko ST, Mason GE, Mason AL. Primary biliary cirrhosis, bacteria and molecular mimicry: what’s the molecule and where’s the mimic? Liver Int 2009;29:779-782.","DOI":"10.1111\/j.1478-3231.2009.02051.x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-014-0460-7"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.03.053"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Mason AL, Zhang G. Linking human beta retrovirus infection with primary biliary cirrhosis. Gastroenterol Clin Biol 2010;34:359-366.","DOI":"10.1016\/j.gcb.2010.04.014"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Poupon R, Poupon RE. Retrovirus infection as a trigger for primary biliary cirrhosis? Lancet 2004;363:260-261.","DOI":"10.1016\/S0140-6736(03)15418-9"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mason A, Xu L, Neuberger J. Proof of principal studies to assess the role of the human betaretrovirus in patients with primary biliary cirrhosis. Am J Gastroenterol 2004;99:2499-2500.","DOI":"10.1111\/j.1572-0241.2004.41389_1.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL. Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis. Liver Int 2010;30:871-877.","DOI":"10.1111\/j.1478-3231.2010.02257.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12699"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM. Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol 2004;99:2348-2355.","DOI":"10.1111\/j.1572-0241.2004.40741.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03799.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12575"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Xu L, Guo L, Shen Z, Loss G, Gish R, Wasilenko S, Mason AL. Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int 2009;29:375-383.","DOI":"10.1111\/j.1478-3231.2008.01888.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998;351:1620-1624.","DOI":"10.1016\/S0140-6736(97)10290-2"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O’Donnell B, Aitken J, Carman W, Neuberger J. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 2003;100:8454-8459.","DOI":"10.1073\/pnas.1433063100"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20024"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Holland JF, Pogo BG. Mouse mammary tumor virus-like viral infection and human breast cancer. Clin Cancer Res 2004;10:5647-5649.","DOI":"10.1158\/1078-0432.CCR-04-1234"},{"key":"ref17","unstructured":"Pogo BG, Holland JF. Possibilities of a viral etiology for human breast cancer. A review. Biol Trace Elem Res 1997;56:131-142."},{"key":"ref18","unstructured":"Bentvelzen P. The biology of the mouse mammary tumor virus. Int Rev Exp Pathol 1972;11:259-297."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Mason AL. The evidence supports a viral aetiology for primary biliary cirrhosis. J Hepatol 2011;54:1312-1314.","DOI":"10.1016\/j.jhep.2010.12.009"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Acha-Orbea H, Palmer E. Mls--a retrovirus exploits the immune system. Immunol Today 1991;12:356-361.","DOI":"10.1016\/0167-5699(91)90066-3"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Johal H, Scott GM, Jones R, Camaris C, Riordan S, Rawlinson WD. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol 2009;50:548-554.","DOI":"10.1016\/j.jhep.2008.10.026"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Selmi C, Ross SR, Ansari AA, Invernizzi P, Podda M, Coppel RL, Gershwin ME. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004;127:493-501.","DOI":"10.1053\/j.gastro.2004.05.033"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13054"},{"key":"ref24","unstructured":"Wang W, Wasilenko S, Indik S, Wong G, Mason A. Isolation of the human betaretrovirus and demonstration of integration sites in patients with primary biliary cirrhosis. Canadian J Gastroenterol 2012;26:84A."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03402.x"},{"key":"ref26","unstructured":"Gish RG, Mason A. Autoimmune liver disease. Current standards, future directions. Clin Liver Dis 2001;5:287-314."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010;52:745-758.","DOI":"10.1016\/j.jhep.2009.11.027"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Joplin R, Gershwin ME. Ductular expression of autoantigens in primary biliary cirrhosis. Semin Liver Dis 1997;17:97-103.","DOI":"10.1055\/s-2007-1007187"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998;352:1595-1596.","DOI":"10.1016\/S0140-6736(05)61042-2"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Zhang G, Chen M, Graham D, Subsin B, McDougall C, Gilady S, Kneteman M, Law L, Swain M, Trauner M. Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models. J Hepatol 2011;55:876-884.","DOI":"10.1016\/j.jhep.2011.01.037"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Mason AL. An autoimmune biliary disease mouse model for primary biliary cirrhosis: something for everyone. Hepatology 2006;44:1047-1050.","DOI":"10.1002\/hep.21390"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Irie J, Wu Y, Wicker LS, Rainbow D, Nalesnik MA, Hirsch R, Peterson LB, Leung PS, Cheng C, Mackay IR. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006;203:1209-1219.","DOI":"10.1084\/jem.20051911"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Koarada S, Wu Y, Fertig N, Sass DA, Nalesnik M, Todd JA, Lyons PA, Fenyk-Melody J, Rainbow DB, Wicker LS. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004;173:2315-2323.","DOI":"10.4049\/jimmunol.173.4.2315"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wakabayashi K, Lian ZX, Moritoki Y, Lan RY, Tsuneyama K, Chuang YH, Yang GX, Ridgway W, Ueno Y, Ansari AA. IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis. Hepatology 2006;44:1240-1249.","DOI":"10.1002\/hep.21385"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS, Ridgway WM, Ansari AA, Coppel RL, Li MO. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006;177:1655-1660.","DOI":"10.4049\/jimmunol.177.3.1655"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22651"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000;12:171-181.","DOI":"10.1016\/S1074-7613(00)80170-3"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007;120:744-750; quiz 751-752.","DOI":"10.1016\/j.jaci.2007.08.044"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3:521-530.","DOI":"10.1016\/1074-7613(95)90180-9"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nature11599"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.07.018"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Held W, Waanders GA, Acha-Orbea H, MacDonald HR. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J Exp Med 1994;180:2347-2351.","DOI":"10.1084\/jem.180.6.2347"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/01.COH.0000239849.20828.09"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Lammers WJ, Kowdley KV, van Buuren HR. Predicting outcome in primary biliary cirrhosis. Ann Hepatol 2014;13:316-326.","DOI":"10.1016\/S1665-2681(19)30838-5"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Lammers W, Janssen H, Invernizzi P, Battezzati P, Floreani A, Hirschfield G, Pares A, Ponsioen C, Corpechot C, Mayo M. Identification of PBC patients in need of additional therapy during the course of UDCA treatment - an international multicenter study. J Hepatol 2015;62:S796.","DOI":"10.1016\/S0168-8278(15)31376-3"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20897"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.06.008"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23637"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.005"},{"key":"ref52","unstructured":"Suriawinata AA, Thung SN. Liver Pathology: An Atlas and Concise Guide : Demos Medical Publishing; 2011;."},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Degott C, Zafrani ES, Callard P, Balkau B, Poupon RE, Poupon R. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999;29:1007-1012.","DOI":"10.1002\/hep.510290444"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80216-0"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999;29:644-647.","DOI":"10.1002\/hep.510290301"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00869.x"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Wolfhagen FH, van Hoogstraten HJ, van Buuren HR, van Berge-Henegouwen GP, ten Kate FJ, Hop WC, van der Hoek EW, Kerbert MJ, van Lijf HH, den Ouden JW. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. J Hepatol 1998;29:736-742.","DOI":"10.1016\/S0168-8278(98)80254-7"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Levy C, Lindor KD. Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2003;38 Suppl 1:S24-S37.","DOI":"10.1016\/S0168-8278(03)00006-0"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Oo YH, Neuberger J. Options for treatment of primary biliary cirrhosis. Drugs 2004;64:2261-2271.","DOI":"10.2165\/00003495-200464200-00001"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980;78:1005-1010.","DOI":"10.1016\/0016-5085(80)90784-2"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986;91:1327-1334.","DOI":"10.1016\/0016-5085(86)90183-6"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.","DOI":"10.1056\/NEJM199611213352107"},{"key":"ref63","unstructured":"Luketic VA, Invernizzi P, Trauner M, Regula J, Mazzella G, Strasser SI, Floreani A, Hohenester S, van Erpecum KJ, Pockros PJ. Efficacy of Obeticholic Acid In Primary Biliary Cirrhosis as Assessed by Response Criteria Associated With Clinical Outcome: A Poise Analysis. Proceedings of the Hepatology NJ: Wiley-Blackwell; 2014;355A-356A."},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.","DOI":"10.1056\/NEJM199803263381301"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)61343-8"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Nair S, Khan S, Loss G, Eason J, Blazek J, Lipscomb J, Mason A. Treatment of recurrent hepatitis C in liver transplant recipients: is there any histologic benefit? Liver Transpl 2003;9:354-359.","DOI":"10.1053\/jlts.2003.50068"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"McDermid J, Chen M, Li Y, Wasilenko S, Bintner J, McDougall C, Pang X, Bain VG, Mason AL. Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 2007;26:587-595.","DOI":"10.1111\/j.1365-2036.2007.03402.x"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2011.09.017"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055943"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2012.08.019"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02620-12"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, Heathcote EJ, Hirschfield GM. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol 2010;105:2186-2194.","DOI":"10.1038\/ajg.2010.216"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02678.x"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23082"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23631"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i1\/349.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:54:09Z","timestamp":1567464849000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i1\/349.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i1.349","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726070347.793513535","asserted-by":"object"}]},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}